Search Bar & Filters
Found 2 Actively Recruiting clinical trials
Actively Recruiting
Researchers are evaluating the effects of muvalaplin in reducing the risk of major cardiovascular events in adults with elevated lipoproteina levels who either have cardiovascular disease or are at risk for a heart attack or stroke. This Phase 3, randomized, double-blind, placebo-controlled study focuses on adults with high lipoproteina and a history or risk of atherosclerotic cardiovascular events. The study aims to better understand if muvalaplin can lower the occurrence of serious heart-related problems. Participants will be randomly assigned to receive either muvalaplin or a placebo, both taken orally. The study compares these two groups over about 5.25 years to assess the impact of muvalaplin on major adverse cardiac events. The research includes ongoing monitoring of lipoproteina levels and other cardiovascular outcomes throughout this period. During the study, participants will undergo regular assessments including measuring changes in lipoproteina, tracking the time to occurrence of major cardiovascular events, and monitoring overall health outcomes. Researchers will collect data on healthcare resource usage and drug levels in the body. The long-term follow-up allows for thorough evaluation of muvalaplins effects on heart health and safety over more than five years.
Actively Recruiting
Researchers are developing and testing a national audit for musculoskeletal MSK care in community and primary care settings. This observational study aims to collect patient and clinician data to measure and improve the quality and consistency of care for common MSK conditions. The project focuses on using this information to support ongoing quality improvement for MSK patients across different care services. The study involves two groups First Contact Practitioner FCP primary care services and MSK Community Services. Each group will recruit patients who will complete baseline and 3-month questionnaires about their outcomes and experiences. Additionally, organisational data will be collected from service leads and publicly available sources. The FCP group will also provide electronic health record data via a standardized template. Data collection occurs continuously with targeted recruitment numbers per service each year. Participants aged 18 and older with access to phone or email and able to consent will be involved. Researchers will gather patient surveys, organisational characteristics, and electronic health records to create a secure national MSK research database. The main outcome is establishing this database over 12 months. Secondary outcomes include developing dashboards and reports to help with quality improvement. Participation involves completing questionnaires at baseline and three months, with ongoing data collection throughout the study.